OLFACTION AND BIPOLAR DISODER

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06809881

Acronym

OLF-BP

Enrollment

240

Registered

2025-02-05

Start date

2016-01-01

Completion date

2020-01-01

Last updated

2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Brief summary

To compare olfactory performance between patients with BD and HC and correlate their performances to neuroimaging data

Interventions

OTHERolfactory testing, MRI acquisition, clinical assessment

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with BD and HC * Fluent in french * Having a public health insurance * Not being on tutorship

Exclusion criteria

* Family history of bipolar disorder for controls * Alcohol dependence

Design outcomes

Primary

Measure	Time frame	Description
Olfactive performance	through study completion, an average of 4 years	Testing of olfactory performance (odor threshold, odor discrimination, odor identification)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026